Court acquits last suspect in deadly Sefalana robbery

The Village Magistrate’s Court this week acquitted Kabo Moremong, the sole remaining suspect in the high-profile 2022 robbery at Sefalana Cash and Carry, involving P649,863.75 in stolen cash. The verdict marks a dramatic and unexpected end to a legal saga born from one of the most violent and tragic cash-in-transit heists in recent memory. Presiding over the case, the magistrate ruled that the State had failed to prove beyond a reasonable doubt that Moremong had...

Appeal Court hands Pro-Serve major contract victory

Pro-Serve Consulting Botswana has secured a significant legal victory after the Court of Appeal overturned a High Court order that had frozen funds linked to the Modipane-Mabalane Road project and restricted the company from managing aspects of the contract. In a judgment delivered on Friday, the Court of Appeal ruled that Tau Grading & Building Construction failed to satisfy the legal requirements for an anti-dissipation order and had not shown exceptional circumstances to justify approaching...

Cyber resilience will determine who wins Botswana’s digital future

There’s a noticeable shift taking place across Botswana. Organisations have moved from asking whether they should digitise to how quickly they can adopt technologies such as cloud computing and AI to improve how they operate and serve customers. That shift is being enabled by strong foundations. One of Africa’s most sophisticated financial sectors, widespread broadband connectivity and continued investment in digital infrastructure have created the conditions for the next phase of digital growth. We see...

ADB, Biovac forge $15 million deal to boost Africa’s vaccine production

The African Development Bank Group has finalized a $15 million loan to the Biologicals and Vaccines Institute of South Africa Ltd (Biovac) to support the development of a new multi-vaccine manufacturing facility in Cape Town. This investment will dramatically expand Africa’s capacity to produce vaccines domestically. The funding is part of a broader expansion plan that will increase Biovac’s annual production capacity to 500 million doses. When complete, Biovac will become the continent’s first end-to-end...